Applications of fat grafting in the treatment of radiation-induced wounds
After exposure to radiation, radiation- induced skin damage can manifest acutely or chronically. The acute manifestations of radiation-induced skin damage include a radiodermatitis-like reaction featuring localized thickening and desquamation of the epidermis. These changes are often the result of a radiation-induced inflammatory reaction precipitating hyperpermeability and progressive occlusion of dermal capillary vessels, which results in perivascular edema, erythema, and pruritus.1,2 Proinflammatory cytokines such as interleukin (IL)-1 and IL-8 are increased and overexpression of interferon (IFN)-γ, tumor necrosis factor (TNF)-α and transforming growth factor (TGF)-ß is seen. Stem cell proliferation mechanisms replace the lost functional cells slowly over time.
However, even in the absence of acute manifestations, radiation exposure may cause later findings, such as increased vascular density of affected tissues, skin ulcers, or osteoradionecrosis as a result of chronic fibrotic processes that tend to worsen over time.3 Radiation disrupts the wound healing cascade as pro-inflammatory cytokines and fibrin infiltrate the tissue, collagen is deposited, and fibrogenesis is induced by chronic hypoxia, tissue ischemia and atrophy. Dysregulation of matrix metalloproteinases also cause fibroblast deposition of disorganized collagen into the wound bed. Release of reactive oxygen species and free radicals cause further damage to DNA.
In cases of radiation exposure greater than 24 Sv, these pathologic changes can result in secondary skin ulceration that classically presents 6 weeks or more after radiation exposure.4 In these cases, one possible solution involves the use of fat grafting, which has been shown to reverse radiation-induced skin changes via processes thought to be mediated by multipotent adipose tissue-derived stem cells (ADSCs).5 These ADSCs have differentiation properties similar to those of bone marrow–derived mesenchymal stem cells, and they have been shown to secrete angiogenic and antiapoptotic factors and differentiate into endothelial cells and incorporate into vessels.6,7
The applications of fat grafting in reconstructive surgery have been well documented; breast cancer patients with radiotherapy-induced breast wounds who received fat grafting exhibit greater improvements in wound healing, clinical symptoms, and long-term aesthetic scores compared with patients who did not receive fat grafting.8 The use of fat grafting to promote healing in radiation-induced skin damage in murine models has also been documented. Animal models with radiation-induced skin damage who received fat grafting exhibit decreased epidermal thickening, collagen deposition, vascular density, and wound size in comparison to sham-grafted counterparts.9,10 Moreover, immunoblot and histologic analyses of radiation-induced wounds treated with fat grafting have shown co-localization of ADSCs with endothelial cell markers in ulcerated tissues, again suggesting ADSCs as possible mediators of healing in these models.11
Considerations involving the present case
The use of fat grafting to attenuate local vessel depletion and promote healing of radiation-induced skin damage has been well documented in murine models.9,11-13 However, few reports to date have demonstrated its use in human models or detailed the efficacy of fat grafting in comparison with other treatment modalities, such as topical pharmacologic use, HBOT, repeated wound debridement, or surgery.14 The patient detailed in this report developed a radiation-induced skin wound refractory to multiple interventions, including more than 30 visits to dermatology for debridement and over 40 visits for HBOT. The goals of HBOT were to re-establish wound tissue oxygen gradients and thereby stimulate angiogenesis within areas of radiation-induced obliterative endarteritis, and also to provide a competent vascular foundation to support the ensuing reconstructive procedure. Wound healing was achieved after his fat grafting procedure, which was performed 19 months after initial presentation. During the procedure, harvested adipose fat was separated into microfat and nanofat, with microfat injected in a deep subcutaneous plane and nanofat injected into a more superficial plane. Due to their diminutive size, the overlying nanofat particles may lack important components for structural support of adipocytes, such as fibroblasts, blood vessels, and connective tissue. Although the nanofat particles may not contain adipocytes with long-term viability, they may retain a rich supply of ADSCs that are thought to offer improved skin quality postoperatively.15 In fact, a number of studies have demonstrated superior effects of cell-assisted lipotransfer over standard fat grafting. In C cell-assisted lipotransfer, fat grafts are enriched with the stromal vascular fraction of the lipoaspirate, or with ADSCs expanded in culture. In both animal and human experimental models, cell-assisted lipotransfer increased the volume of fat retained in irradiated skin and enhanced the ability of fat to attenuate radiation-induced dermal thickening.16-20
Complications of fat grafting are rare but may include fat necrosis, infection, hematoma, oil cysts, calcifications and theoretical risk of cancer recurrence. Infection may be related to limited T lymphocyte activity in fat-grafted areas due to anti-inflammatory properties of the lipoaspirates. In the months before our patient’s fat grafting procedure, he developed repeated Pseudomonas-associated wound infections as a result of his radiation-induced skin damage, so proceeding with fat grafting was thought to be a means of limiting future infections and complications. After the procedure, this patient was discharged with a 7-day course of trimethoprim-sulfamethoxazole (Bactrim) and did not experience any postsurgical complications. Other complications of fat grafting in resolving radiation-induced skin damage may include damage to veins or small arteries causing ecchymosis or hematomas.